NeuroOne Medical Technologies Corporation (NMTC) — 分析师展望 / 分析师共识目标价为. 基于 2 位分析师评级, 共识为 看涨 — 1 买入, 1 持有.
分析师共识目标价为 $3.00, 上涨空间为 311% 相对于当前价格 $0.73.
分析师预估 每股收益(EPS)为 $-0.41 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-0.46 vs 预期 $-0.41 (不及预期 -12.2%). 2025: 实际 $-0.09 vs 预期 $-0.12 (超预期 +21.7%). 分析师准确度: 81%.
NMTC 股票 — 12个月价格预测
$3.00
▲ +310.96% 上涨空间
平均目标价
Based on 2 Wall Street analysts offering 12-month price targets for NeuroOne Medical Technologies Corporation, the price target is $3.00.
平均目标价相对最新价格 $0.73 变动 +310.96%。
NMTC 分析师评级
Buy
基于过去3个月内 2 位分析师对 NeuroOne Medical Technologies Corporation 的评级
EPS 预测 — NMTC
81%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.46
vs Est –$0.41
▼ 10.9% off
2025
Actual –$0.09
vs Est –$0.12
▲ 27.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — NMTC
57%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.003B
vs Est $0.006B
▼ 59.3% off
2025
Actual $0.012B
vs Est $0.009B
▲ 26.4% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
